Funding for this research was provided by:
Health Research Council of New Zealand (14-527)
Text and Data Mining valid from 2018-07-05
Received: 30 November 2017
Accepted: 18 May 2018
First Online: 5 July 2018
Ethics approval and consent to participate
: UK Biobank obtained approval from the North West Multi-Centre Research Ethics Committee (11/NW/0382). Full written informed consent was obtained from all participants prior to the study.
: TRM has received consulting fees or grants from Ardea Biosciences and AstraZeneca. ND has received consulting fees, speaker fees, or grants from Takeda, Teijin, Menarini, Pfizer, Ardea Biosciences, AstraZeneca, Fonterra, Crealta, and Cymabay. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.